Analgesic Efficacy of Low Doses of Dexketoprofen in the Dental Pain Model
Dexketoprofen (S(+)-2-(3-benzoylphenyl)propionic acid) is the active enantiomer of ketoprofen, a racemic nonsteroidal anti-inflammatory drug with proven analgesic activity in the treatment of pain, including acute pain after dental surgery. The aim of this randomised, double-blind study was to compare the analgesic efficacy of single oral doses (5, 10 and 20mg) of the tromethamine salt of dexketoprofen (DKR.TRIS) [equivalent to 3.5, 7 and 14mg of dexketoprofen, respectively] with that of placebo in the dental pain model. Ibuprofen (400mg) was used to validate the model. A total of 206 patients experiencing moderate to severe pain after surgical removal of the impacted third molar tooth under local anaesthesia were entered in this trial at 2 centres. Patients rated their pain intensity and pain relief on verbal rating and visual analogue scales at regular intervals during the 6-hour period after drug administration. Patients were also requested to provide a global evaluation of treatment efficacy at the end of the observation period. DKR.TRIS (10 and 20mg) and ibuprofen were superior to placebo as determined by significantly higher values for the sum of the pain intensity difference scores and total pain relief scores from baseline. Furthermore, the time to reduce baseline pain by at least 50% was significantly more rapid in patients treated with DKR.TRIS (10 and 20mg) and ibuprofen than in placebo recipients. The mean time to remedication with rescue analgesia was significantly longer in all active treatment groups compared with placebo. DKR.TRIS was well tolerated, with a reported incidence of adverse events similar to that of placebo. No serious adverse events were reported in any treatment group. The results of this study suggest that DKR.TRIS is an effective analgesic with a favourable tolerability profile for the treatment of acute pain states.
Unable to display preview. Download preview PDF.
- 2.Vane JR. The mode of action of aspirin and similar compounds. Hosp Form 1976; 10: 618–29Google Scholar
- 4.Sunshine A, Olson NZ. Analgesic efficacy of ketoprofen in postpartum, general surgery and chronic cancer pain. J Clin Pharmacol 1988; 28 Suppl.: 47–54Google Scholar
- 5.Turek MD, Baird WM. Double-blind parallel comparison of ketoprofen (Orudis), acetaminophen plus codeine, and placebo in postoperative pain. J Clin Pharmacol 1988; 28 Suppl.: 23–8Google Scholar
- 6.Fossgreen J. Ketoprofen. A survey of current publications. Scand J Rheumatol 1976; 14 Suppl.: 7–32Google Scholar
- 8.Muller-Fassbender H, Reiter W, Eveld H. Open multicenter long term trial (3 years) on efficacy and tolerance of ketoprofen (Orudis capsules) in rheumatology: final assessment. Curr Ther Res 1984; 36: 1221–7Google Scholar
- 9.van der Meij T, van Harten RPW. Evaluation of the efficacy and tolerance of Orudis 100mg in osteoarthritis in general practice. Clin Exp Rheumatol 1987; 5: 88Google Scholar
- 11.Cooper SA, Gelb SB, Cavaliere MBM, et al. An analgesic relative potency assay comparing ketoprofen and aspirin in postoperative dental pain. Adv Ther 1984; 1: 410–8Google Scholar
- 12.Mehlish D, Frakes L, Cavaliere MBM, et al. Double-blind parallel comparison of single oral doses of ketoprofen, codeine and placebo in patients with moderate to severe dental pain. J Clin Pharmacol 1984; 24: 486–92Google Scholar
- 13.Cooper SA, Berrie R, Cohn P. Comparison of ketoprofen, ibuprofen and placebo in dental pain surgery model. Adv Ther 1988; 5: 43–53Google Scholar
- 20.Gich I, Barbanoj MJ, Artigas R, et al. New fast onset formulation of dexketoprofen. 6th Interscience World Conference on Inflammation, Antirheumatics Analgesics Immunomodulators 95: 1995 Mar 28–30: GenevaGoogle Scholar
- 21.Max MB, Laska EM. Single-dose analgesic comparisons. Max M, Portenoy R, Laska E, editors. Advances in pain research and therapy. Vol. 18, New York: Raven Press, 1991: 55–95Google Scholar
- 23.Einot I, Gabriel KR. A study of the powers of several methods of multiple comparisons. J Am Stat Soc 1975; 70: 351Google Scholar
- 29.Guideline for the clinical evaluation of analgesic drugs. U.S. Department of Health and Human Services. Public Health Service, Food and Drug Administration, 1992Google Scholar